Suppr超能文献

使用喷雾干燥的醋酸壳聚糖和羟丙基甲基纤维素开发时间、pH值和酶控制的结肠药物递送系统。

Development of time-, pH-, and enzyme-controlled colonic drug delivery using spray-dried chitosan acetate and hydroxypropyl methylcellulose.

作者信息

Nunthanid Jurairat, Huanbutta Kampanart, Luangtana-Anan Manee, Sriamornsak Pornsak, Limmatvapirat Sontaya, Puttipipatkhachorn Satit

机构信息

Department of Pharmaceutical Technology, Silpakorn University, Nakhon Pathom, Thailand.

出版信息

Eur J Pharm Biopharm. 2008 Feb;68(2):253-9. doi: 10.1016/j.ejpb.2007.05.017. Epub 2007 Jun 15.

Abstract

A colonic drug delivery with a new concept based on a combination of time-, pH-, and enzyme-controlled system was developed. Spray-dried chitosan acetate (CSA) prepared from low molecular weight chitosan was characterized. A combination of CSA and hydroxypropyl methylcellulose (HPMC) was used as new compression-coats for 5-aminosalicylic acid (5-ASA) tablets. Factors affecting in-vitro drug release, i.e. % weight ratio of coating polymers, enzyme activity, pH of media, and excipients in core tablets, were evaluated. The tablets compression-coated with HPMC:CSA at 60:40 and 50:50% weight ratio providing lag times about 5-6h were able to pass through the stomach (stage I, 0.1N HCl) and small intestine (stage II, pH 6.8, Tris-HCl). The delayed release was time- and pH-controlled owing to the swelling with gradual dissolving of CSA and HPMC in 0.1N HCl and the less solubility of CSA at higher pH. After reaching the colon (stage III, pH 5.0, acetate buffer), the dissolution of CSA at low pH triggered the drug release over 90% within 14h. Furthermore, the degradation of CSA by beta-glucosidase in the colonic fluid enhanced the drug release while adding the disintegrant or the osmotic agent in the core tablets would affect the drug release.

摘要

基于时间、pH值和酶控制体系相结合的新概念结肠给药系统被研发出来。对由低分子量壳聚糖制备的喷雾干燥醋酸壳聚糖(CSA)进行了表征。将CSA与羟丙基甲基纤维素(HPMC)的组合用作5-氨基水杨酸(5-ASA)片剂的新型压制包衣。评估了影响体外药物释放的因素,即包衣聚合物的重量百分比、酶活性、介质的pH值以及片芯中的辅料。以60:40和50:50重量比的HPMC:CSA压制包衣的片剂,其滞后时间约为5-6小时,能够通过胃(第一阶段,0.1N盐酸)和小肠(第二阶段,pH 6.8,Tris-HCl)。延迟释放是由时间和pH值控制的,这是由于CSA和HPMC在0.1N盐酸中逐渐溶解并溶胀,以及CSA在较高pH值下溶解度较低。到达结肠(第三阶段,pH 5.0,醋酸盐缓冲液)后,CSA在低pH值下的溶解促使药物在14小时内释放超过90%。此外,结肠液中β-葡萄糖苷酶对CSA的降解增强了药物释放,而在片芯中加入崩解剂或渗透剂会影响药物释放。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验